MYCMI-6
MYCMI-6 is a selective small molecule inhibitor that disrupts the MYC:MAX protein interaction. It demonstrates potent anti-tumor activity in MYC-driven models, significantly reducing proliferation and inducing apoptosis in vivo with a favorable toxicity profile. This inhibitor is a valuable research tool for studying MYC biology and oncology in both cellular and animal experiments.
Product Specifications
CAS Number
681282-09-7
Product Name Alternative
Athymic, Apoptosis, cytotoxic, cMyc, c-Myc, c-Myc-MAX, cells, nude, mice, neuroblastoma, Myc, MYCMI 6, MYCMI6, MYCMI-6, MYC-driven, inhibit, NSC 354961, NSC354961, NSC-354961, lymphoma, MCF7, Inhibitor, tumor
Field of Research
Cell Biology
Purity
97.77% (May vary between batches)
Solubility
DMSO:2.3 mg/mL (6.16 mM)
Smiles
CCOc1ccc2nc3cc (ccc3c (N) c2c1) \N=N\c1ccc (N) nc1N
Molecular Formula
C20H19N7O
Molecular Weight
373.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
A-4752_P00-01 1 g
Aldol® 495 beta-D-glucuronic acid, Biosynth Patent: EP 2427431 and US 8940909
Sign In for Pricing
View Details 
A-4752_P00-02 2.5 g
Aldol® 495 beta-D-glucuronic acid, Biosynth Patent: EP 2427431 and US 8940909
Sign In for Pricing
View Details 
A-4752_P00-03 5 g
Aldol® 495 beta-D-glucuronic acid, Biosynth Patent: EP 2427431 and US 8940909
Sign In for Pricing
View Details A-4752_P00-04 10 g
Aldol® 495 beta-D-glucuronic acid, Biosynth Patent: EP 2427431 and US 8940909
Sign In for Pricing
View Details MR212287L3V 200 µL
Gm11756 (NM_001126326) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details